January 25, 2023

Matthew Zirwas, MD: What's New in Systemics in Atopic Dermatitis

January 27, 2023

Dr. Zirwas reviews new advancements in systemics for atopic dermatitis including JAK inhibitors and the current black box warnings for these treatments.

More Maui Derm 2023 Video Coverage

Michael Gold, MD: Laser and Light Session at Maui Derm 2023

Joel Cohen, MD: Heavy Laser Resurfacing

Joel Cohen, MD: New Lasers for Acne Treatment

Raj Chovatiya, MD, PhD: Exceptional Eczematous Expertise

Sheila Fallon Friedlander, MD: What’s New in Pediatric Dermatology

Sheila Fallon Friedlander, MD: Literature Update 2023 in Pediatric Dermatology

Phil Werschler, MD: Cosmetic Dermatology Sessions at Maui Derm 2023

Dee Anna Glaser, MD: Emerging Toxins and Fillers in 2023

Suneel Chilukuri, MD: What’s New in Toxins, Fillers, and Aesthetic Devices

Ted Rosen, MD: New Drugs and Devices at Maui Derm 2023

Ted Rosen, MD: What’s New in Actinic Keratoses

John Harris, MD, PhD: Developments in JAK Inhibitors for Vitiligo

Andy Blauvelt, MD, MBA: Safety Data on JAK Inhibitors for Atopic Dermatitis

Lawrence Eichenfield, MD: What’s New in Pediatric Atopic Dermatitis

Ava Shamban, MD: Improving Injection Patterns with Daxibotulinumtoxina

Daniel Siegel, MD: Coding and Reimbursement

Leon Kircik, MD: JAK Inhibitors in Dermatology

Lawrence Eichenfield, MD: What’s New in Pediatric Acne

Matthew Zirwas, MD: Contact Dermatitis Update 2023

Michael Gold, MD: Laser and Light Session at Maui Derm 2023

Joel Cohen, MD: Heavy Laser Resurfacing

Michael Gold, MD: Laser and Light Session at Maui Derm 2023

Joel Cohen, MD: Heavy Laser Resurfacing

More Maui Derm 2023 Video Coverage

Neal Bhatia, MD: New Therapies in the Field of Dermatology

Dr. Bhatia reviews an array of new therapies discussed during his New Drugs and Therapies presentation at Maui Derm 2023....

Neal Bhatia, MD: New Opportunities for JAK Inhibitors

Dr. Bhatia gives an overview of the utilization of JAK inhibitors in diseases such as hidradenitis suppurativa, vitiligo, alopecia areata, psoriasis, and atopic dermatitis....

Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata

Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata....

Linda Stein Gold, MD: Exploring the Impact of Novel TYK2 Inhibitors in Plaque Psoriasis

Dr. Stein Gold discusses her presentation at Maui Derm 2023 which focused on new TYK2 inhibitors for the treatment of plaque psoriasis, along with other exciting drugs on the horizon....

Linda Stein Gold, MD: Biggest Misconceptions Regarding Mild-to-Moderate Psoriasis

Dr. Stein Gold discusses various misconceptions of localized psoriasis and stresses that topical therapy remains the mainstay of treatment for this disease....

Mark Kaufmann, MD: How to Maximize Your Billing Effectiveness In The Era of Dwindling Reimbursements and ICD-10

Dr. Kaufmann reviews his session regarding coding and reimbursement issues at the end of 2022 with hopes to better keep up with inflation in 2023....